After we treated HCC cell lines with inhibitors of p53 (Pifithrin-β) and STAT3(HO-3867), we found a respective and complete reversion of the increased migration and invasion of HCC cell lines by circulating neutrophils (Fig 3C, Fig 3D, Fig 3E). Here, TP53 is linked to hepatocellular carcinoma.